CDK12 Activity-Dependent Phosphorylation Events in Human Cells

Biomolecules. 2019 Oct 22;9(10):634. doi: 10.3390/biom9100634.

Abstract

We asked whether the C-terminal repeat domain (CTD) kinase, CDK12/CyclinK, phosphorylates substrates in addition to the CTD of RPB1, using our CDK12analog-sensitive HeLa cell line to investigate CDK12 activity-dependent phosphorylation events in human cells. Characterizing the phospho-proteome before and after selective inhibition of CDK12 activity by the analog 1-NM-PP1, we identified 5,644 distinct phospho-peptides, among which were 50 whose average relative amount decreased more than 2-fold after 30 min of inhibition (none of these derived from RPB1). Half of the phospho-peptides actually showed >3-fold decreases, and a dozen showed decreases of 5-fold or more. As might be expected, the 40 proteins that gave rise to the 50 affected phospho-peptides mostly function in processes that have been linked to CDK12, such as transcription and RNA processing. However, the results also suggest roles for CDK12 in other events, notably mRNA nuclear export, cell differentiation and mitosis. While a number of the more-affected sites resemble the CTD in amino acid sequence and are likely direct CDK12 substrates, other highly-affected sites are not CTD-like, and their decreased phosphorylation may be a secondary (downstream) effect of CDK12 inhibition.

Keywords: 1-NM-PP1; CTD; RNA polymerase II; RNA processing; TPR; XPC; analog-sensitive CTD kinase; mESC undifferentiated state; mRNA nuclear export; nuclear pore; transcription.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclin-Dependent Kinases / metabolism*
  • HeLa Cells
  • Humans
  • Peptides / pharmacology
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / pharmacology

Substances

  • Peptides
  • Protein Kinase Inhibitors
  • CDK12 protein, human
  • Cyclin-Dependent Kinases